VASP_HUMAN - dbPTM
VASP_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID VASP_HUMAN
UniProt AC P50552
Protein Name Vasodilator-stimulated phosphoprotein
Gene Name VASP
Organism Homo sapiens (Human).
Sequence Length 380
Subcellular Localization Cytoplasm. Cytoplasm, cytoskeleton. Cell junction, focal adhesion. Cell junction, tight junction. Cell projection, lamellipodium membrane. Cell projection, filopodium membrane. Targeted to stress fibers and focal adhesions through interaction with a
Protein Description Ena/VASP proteins are actin-associated proteins involved in a range of processes dependent on cytoskeleton remodeling and cell polarity such as axon guidance, lamellipodial and filopodial dynamics, platelet activation and cell migration. VASP promotes actin filament elongation. It protects the barbed end of growing actin filaments against capping and increases the rate of actin polymerization in the presence of capping protein. VASP stimulates actin filament elongation by promoting the transfer of profilin-bound actin monomers onto the barbed end of growing actin filaments. Plays a role in actin-based mobility of Listeria monocytogenes in host cells. Regulates actin dynamics in platelets and plays an important role in regulating platelet aggregation..
Protein Sequence MSETVICSSRATVMLYDDGNKRWLPAGTGPQAFSRVQIYHNPTANSFRVVGRKMQPDQQVVINCAIVRGVKYNQATPNFHQWRDARQVWGLNFGSKEDAAQFAAGMASALEALEGGGPPPPPALPTWSVPNGPSPEEVEQQKRQQPGPSEHIERRVSNAGGPPAPPAGGPPPPPGPPPPPGPPPPPGLPPSGVPAAAHGAGGGPPPAPPLPAAQGPGGGGAGAPGLAAAIAGAKLRKVSKQEEASGGPTAPKAESGRSGGGGLMEEMNAMLARRRKATQVGEKTPKDESANQEEPEARVPAQSESVRRPWEKNSTTLPRMKSSSSVTTSETQPCTPSSSDYSDLQRVKQELLEEVKKELQKVKEEIIEAFVQELRKRGSP
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
2Acetylation------MSETVICSS
------CCCEEEECC
41.8119413330
2Phosphorylation------MSETVICSS
------CCCEEEECC
41.8130108239
4Phosphorylation----MSETVICSSRA
----CCCEEEECCCC
14.0930108239
8PhosphorylationMSETVICSSRATVML
CCCEEEECCCCEEEE
16.25-
14SulfoxidationCSSRATVMLYDDGNK
ECCCCEEEEEECCCE
2.2030846556
16PhosphorylationSRATVMLYDDGNKRW
CCCEEEEEECCCEEE
8.2225839225
21AcetylationMLYDDGNKRWLPAGT
EEEECCCEEEEECCC
50.9426051181
39PhosphorylationAFSRVQIYHNPTANS
CCCEEEEECCCCCCC
4.3921945579
43PhosphorylationVQIYHNPTANSFRVV
EEEECCCCCCCEEEE
43.7321945579
46PhosphorylationYHNPTANSFRVVGRK
ECCCCCCCEEEEEEC
16.3821945579
68MethylationVINCAIVRGVKYNQA
EEEEEEECCCCCCCC
37.77115385805
71UbiquitinationCAIVRGVKYNQATPN
EEEECCCCCCCCCCC
41.1121890473
71MalonylationCAIVRGVKYNQATPN
EEEECCCCCCCCCCC
41.1126320211
71AcetylationCAIVRGVKYNQATPN
EEEECCCCCCCCCCC
41.1126051181
76PhosphorylationGVKYNQATPNFHQWR
CCCCCCCCCCCHHHH
14.7025690035
126PhosphorylationPPPPALPTWSVPNGP
CCCCCCCCCCCCCCC
31.0828348404
134PhosphorylationWSVPNGPSPEEVEQQ
CCCCCCCCHHHHHHH
46.4728348404
157PhosphorylationEHIERRVSNAGGPPA
HHHHHHHHCCCCCCC
21.1023927012
239PhosphorylationGAKLRKVSKQEEASG
HHHHHHHHCCHHHCC
31.4923927012
240AcetylationAKLRKVSKQEEASGG
HHHHHHHCCHHHCCC
65.7926051181
245PhosphorylationVSKQEEASGGPTAPK
HHCCHHHCCCCCCCC
47.7823403867
249PhosphorylationEEASGGPTAPKAESG
HHHCCCCCCCCHHCC
59.8923927012
252AcetylationSGGPTAPKAESGRSG
CCCCCCCCHHCCCCC
63.427683629
255PhosphorylationPTAPKAESGRSGGGG
CCCCCHHCCCCCCCH
44.3530576142
258PhosphorylationPKAESGRSGGGGLME
CCHHCCCCCCCHHHH
45.3622199227
264SulfoxidationRSGGGGLMEEMNAML
CCCCCHHHHHHHHHH
4.6621406390
276AcetylationAMLARRRKATQVGEK
HHHHHHHHHHHCCCC
54.7126051181
278PhosphorylationLARRRKATQVGEKTP
HHHHHHHHHCCCCCC
27.168182057
283AcetylationKATQVGEKTPKDESA
HHHHCCCCCCCCCCC
65.2919608861
284PhosphorylationATQVGEKTPKDESAN
HHHCCCCCCCCCCCC
31.1323401153
286SumoylationQVGEKTPKDESANQE
HCCCCCCCCCCCCCC
78.38-
286SumoylationQVGEKTPKDESANQE
HCCCCCCCCCCCCCC
78.38-
289PhosphorylationEKTPKDESANQEEPE
CCCCCCCCCCCCCCC
42.5325159151
303PhosphorylationEARVPAQSESVRRPW
CCCCCCCCHHCCCCC
33.6723401153
305PhosphorylationRVPAQSESVRRPWEK
CCCCCCHHCCCCCCC
26.6023401153
312UbiquitinationSVRRPWEKNSTTLPR
HCCCCCCCCCCCCCC
52.94-
314PhosphorylationRRPWEKNSTTLPRMK
CCCCCCCCCCCCCCC
33.5623401153
315PhosphorylationRPWEKNSTTLPRMKS
CCCCCCCCCCCCCCC
41.5723401153
316PhosphorylationPWEKNSTTLPRMKSS
CCCCCCCCCCCCCCC
34.2926846344
321UbiquitinationSTTLPRMKSSSSVTT
CCCCCCCCCCCCCCC
48.76-
321MethylationSTTLPRMKSSSSVTT
CCCCCCCCCCCCCCC
48.76115978835
322PhosphorylationTTLPRMKSSSSVTTS
CCCCCCCCCCCCCCC
26.5522167270
323PhosphorylationTLPRMKSSSSVTTSE
CCCCCCCCCCCCCCC
22.5522167270
324PhosphorylationLPRMKSSSSVTTSET
CCCCCCCCCCCCCCC
35.6022167270
325PhosphorylationPRMKSSSSVTTSETQ
CCCCCCCCCCCCCCC
25.9822167270
327PhosphorylationMKSSSSVTTSETQPC
CCCCCCCCCCCCCCC
26.9322167270
328PhosphorylationKSSSSVTTSETQPCT
CCCCCCCCCCCCCCC
23.5523927012
329PhosphorylationSSSSVTTSETQPCTP
CCCCCCCCCCCCCCC
29.3123927012
331PhosphorylationSSVTTSETQPCTPSS
CCCCCCCCCCCCCCC
37.2623927012
335PhosphorylationTSETQPCTPSSSDYS
CCCCCCCCCCCCCHH
32.6527273156
337PhosphorylationETQPCTPSSSDYSDL
CCCCCCCCCCCHHHH
25.0723927012
338PhosphorylationTQPCTPSSSDYSDLQ
CCCCCCCCCCHHHHH
28.5628152594
339PhosphorylationQPCTPSSSDYSDLQR
CCCCCCCCCHHHHHH
44.9228152594
341PhosphorylationCTPSSSDYSDLQRVK
CCCCCCCHHHHHHHH
13.1623927012
342PhosphorylationTPSSSDYSDLQRVKQ
CCCCCCHHHHHHHHH
36.5128152594
348UbiquitinationYSDLQRVKQELLEEV
HHHHHHHHHHHHHHH
40.00-
348AcetylationYSDLQRVKQELLEEV
HHHHHHHHHHHHHHH
40.0026051181
356AcetylationQELLEEVKKELQKVK
HHHHHHHHHHHHHHH
43.7526051181
363UbiquitinationKKELQKVKEEIIEAF
HHHHHHHHHHHHHHH
57.5821890473
363AcetylationKKELQKVKEEIIEAF
HHHHHHHHHHHHHHH
57.5826051181

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
39YPhosphorylationKinaseALKQ9UM73
PSP
157SPhosphorylationKinasePKG/CGK_GROUP-PhosphoELM
157SPhosphorylationKinasePKA-Uniprot
157SPhosphorylationKinasePKG-FAMILY-GPS
157SPhosphorylationKinasePKC-FAMILY-GPS
157SPhosphorylationKinasePKC-Uniprot
157SPhosphorylationKinasePKA-FAMILY-GPS
157SPhosphorylationKinaseROCK1Q13464
Uniprot
157SPhosphorylationKinasePRKD2Q9BZL6
PSP
157SPhosphorylationKinasePRKD1Q15139
PSP
157SPhosphorylationKinasePRKCAP17252
GPS
157SPhosphorylationKinasePKG1Q13976
PSP
157SPhosphorylationKinasePKA_GROUP-PhosphoELM
157SPhosphorylationKinasePRKG1P00516
GPS
157SPhosphorylationKinasePRKACAP00517
GPS
157SPhosphorylationKinasePKACAP17612
PSP
239SPhosphorylationKinasePKG-FAMILY-GPS
239SPhosphorylationKinasePKG1Q13976
PSP
239SPhosphorylationKinasePRKACAP00517
GPS
239SPhosphorylationKinasePKA-FAMILY-GPS
239SPhosphorylationKinasePKACAP17612
PSP
239SPhosphorylationKinasePKA-Uniprot
239SPhosphorylationKinasePKA_GROUP-PhosphoELM
239SPhosphorylationKinasePRKD2Q9BZL6
PSP
239SPhosphorylationKinasePKG/CGK_GROUP-PhosphoELM
239SPhosphorylationKinasePRKG1P00516
GPS
278TPhosphorylationKinasePKA-Uniprot
278TPhosphorylationKinasePKG/CGK_GROUP-PhosphoELM
278TPhosphorylationKinaseRPS6KA1Q15418
GPS
278TPhosphorylationKinasePKA_GROUP-PhosphoELM
278TPhosphorylationKinasePKG-FAMILY-GPS
278TPhosphorylationKinasePKA-FAMILY-GPS
278TPhosphorylationKinaseAMPK-FAMILY-GPS
278TPhosphorylationKinaseAMPKQ9Y478
Uniprot
278TPhosphorylationKinasePKG1Q13976
PSP
278TPhosphorylationKinasePRKACAP17612
GPS
278TPhosphorylationKinasePRKAA1Q13131
GPS
322SPhosphorylationKinasePRKD2Q9BZL6
PSP
322SPhosphorylationKinasePRKD1Q15139
PSP
322SPhosphorylationKinaseAMPKQ9Y478
Uniprot

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference
157SPhosphorylation

8182057
157SPhosphorylation

8182057
157SPhosphorylation

8182057
157SPhosphorylation

8182057
157SPhosphorylation

8182057
157SPhosphorylation

8182057
239SPhosphorylation

8182057
239SPhosphorylation

8182057
239SPhosphorylation

8182057
239SPhosphorylation

8182057
278TPhosphorylation

8182057
278TPhosphorylation

8182057
322SPhosphorylation

18669648

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of VASP_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
DMRTB_HUMANDMRTB1physical
16189514
NOL3_HUMANNOL3physical
16189514
WWP2_HUMANWWP2physical
16189514
TRIM9_HUMANTRIM9physical
16189514
ZYX_HUMANZYXphysical
10882740
PROF1_HUMANPFN1physical
10882740
PROF2_HUMANPFN2physical
10882740
VINC_HUMANVCLphysical
10882740
VASP_HUMANVASPphysical
12220179
IRAK1_HUMANIRAK1physical
20044140
FAN_HUMANNSMAFphysical
17599063
VATC1_HUMANATP6V1C1physical
22939629
VATF_HUMANATP6V1Fphysical
22939629
DMRTB_HUMANDMRTB1physical
19060904
SAT1_HUMANSAT1physical
19060904
1433T_HUMANYWHAQphysical
20618440
DDB1_HUMANDDB1physical
22863883
PAAF1_HUMANPAAF1physical
22863883
PSA5_HUMANPSMA5physical
22863883
XIRP1_HUMANXIRP1physical
16631741
ABI2_HUMANABI2physical
25416956
FR1OP_HUMANFGFR1OPphysical
25416956
ABI3_HUMANABI3physical
25416956
ENAH_HUMANENAHphysical
26186194
GTPB1_HUMANGTPBP1physical
26186194
CYFP2_HUMANCYFIP2physical
26186194
EVL_HUMANEVLphysical
26186194
UTP4_HUMANCIRH1Aphysical
26186194
ABI1_HUMANABI1physical
26186194
LRP4_HUMANLRP4physical
26186194
CTU1_HUMANCTU1physical
26186194
ENAH_HUMANENAHphysical
26344197
EVL_HUMANEVLphysical
26344197
ACTG_HUMANACTG1physical
25241761
GEPH_HUMANGPHNphysical
16376568
ACTN1_HUMANACTN1physical
16376568
EVL_HUMANEVLphysical
28514442
ZYX_HUMANZYXphysical
28514442
ENAH_HUMANENAHphysical
28514442
ABI1_HUMANABI1physical
28514442
GTPB1_HUMANGTPBP1physical
28514442
FR1OP_HUMANFGFR1OPphysical
28514442
UTP4_HUMANCIRH1Aphysical
28514442
CTU1_HUMANCTU1physical
28514442
UFM1_HUMANUFM1physical
27173435
ARPC3_HUMANARPC3physical
27173435
PREP_HUMANPITRM1physical
27173435
CB071_HUMANC2orf71physical
27173435

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of VASP_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Exploring proteomes and analyzing protein processing by massspectrometric identification of sorted N-terminal peptides.";
Gevaert K., Goethals M., Martens L., Van Damme J., Staes A.,Thomas G.R., Vandekerckhove J.;
Nat. Biotechnol. 21:566-569(2003).
Cited for: PROTEIN SEQUENCE OF 2-10, AND ACETYLATION AT SER-2.
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions.";
Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.;
Science 325:834-840(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-283, AND MASS SPECTROMETRY.
Phosphorylation
ReferencePubMed
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-316 AND SER-322, ANDMASS SPECTROMETRY.
"Carbon monoxide and nitric oxide mediate cytoskeletal reorganizationin microvascular cells via vasodilator-stimulated phosphoproteinphosphorylation: evidence for blunted responsiveness in diabetes.";
Li Calzi S., Purich D.L., Chang K.H., Afzal A., Nakagawa T.,Busik J.V., Agarwal A., Segal M.S., Grant M.B.;
Diabetes 57:2488-2494(2008).
Cited for: FUNCTION, SUBCELLULAR LOCATION, AND PHOSPHORYLATION AT SER-157 ANDSER-239.
"Global proteomic profiling of phosphopeptides using electron transferdissociation tandem mass spectrometry.";
Molina H., Horn D.M., Tang N., Mathivanan S., Pandey A.;
Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-239, AND MASSSPECTROMETRY.
"Vasodilator-stimulated phosphoprotein (VASP) is phosphorylated on Ser157 by protein kinase C-dependent and -independent mechanisms inthrombin-stimulated human platelets.";
Wentworth J.K., Pula G., Poole A.W.;
Biochem. J. 393:555-564(2006).
Cited for: PHOSPHORYLATION AT SER-157, AND SUBCELLULAR LOCATION.
"Phosphorylation of focal adhesion vasodilator-stimulatedphosphoprotein at Ser157 in intact human platelets correlates withfibrinogen receptor inhibition.";
Horstrup K., Jablonka B., Honig-Liedl P., Just M., Kochsiek K.,Walter U.;
Eur. J. Biochem. 225:21-27(1994).
Cited for: PHOSPHORYLATION AT SER-157, AND FIBRINOGEN RECEPTOR INHIBITION.
"cAMP- and cGMP-dependent protein kinase phosphorylation sites of thefocal adhesion vasodilator-stimulated phosphoprotein (VASP) in vitroand in intact human platelets.";
Butt E., Abel K., Krieger M., Palm D., Hoppe V., Hoppe J., Walter U.;
J. Biol. Chem. 269:14509-14517(1994).
Cited for: PROTEIN SEQUENCE OF 143-164; 235-244 AND 267-285, AND PHOSPHORYLATIONAT SER-157; SER-239 AND THR-278 BY PRKG1.
"AMP-activated protein kinase impairs endothelial actin cytoskeletonassembly by phosphorylating vasodilator-stimulated phosphoprotein.";
Blume C., Benz P.M., Walter U., Ha J., Kemp B.E., Renne T.;
J. Biol. Chem. 282:4601-4612(2007).
Cited for: PHOSPHORYLATION AT THR-278, MUTAGENESIS OF SER-157; SER-239 ANDTHR-278, AND FUNCTION.
"An extensive survey of tyrosine phosphorylation revealing new sitesin human mammary epithelial cells.";
Heibeck T.H., Ding S.-J., Opresko L.K., Zhao R., Schepmoes A.A.,Yang F., Tolmachev A.V., Monroe M.E., Camp D.G. II, Smith R.D.,Wiley H.S., Qian W.-J.;
J. Proteome Res. 8:3852-3861(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-39, AND MASSSPECTROMETRY.
"Global survey of phosphotyrosine signaling identifies oncogenickinases in lung cancer.";
Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., Nardone J.,Lee K., Reeves C., Li Y., Hu Y., Tan Z., Stokes M., Sullivan L.,Mitchell J., Wetzel R., Macneill J., Ren J.M., Yuan J.,Bakalarski C.E., Villen J., Kornhauser J.M., Smith B., Li D., Zhou X.,Gygi S.P., Gu T.-L., Polakiewicz R.D., Rush J., Comb M.J.;
Cell 131:1190-1203(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-39, AND MASSSPECTROMETRY.
"Immunoaffinity profiling of tyrosine phosphorylation in cancercells.";
Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,Zha X.-M., Polakiewicz R.D., Comb M.J.;
Nat. Biotechnol. 23:94-101(2005).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-39, AND MASSSPECTROMETRY.

TOP